Steve Aselage is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 70,159 shares of BCRX, which is worth approximately $541,627. The most recent transaction as insider was on Jun 12, 2024, when has been sold 6,820 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.2K
0% 3M change
10.77% 12M change
Total Value Held $541,627

STEVE ASELAGE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
6,820 Added 8.86%
70,159 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
16,745 Added 20.91%
63,339 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
12,866 Added 21.64%
46,594 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
$5,297 $9.31 p/Share
569 Added 1.66%
33,728 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$5,000 $16.61 p/Share
301 Added 0.9%
33,159 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
$4,993 $12.06 p/Share
414 Added 1.24%
32,858 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
$4,999 $15.92 p/Share
314 Added 0.96%
32,444 Common Stock
May 28 2021
BUY
Grant, award, or other acquisition
$9,998 $15.77 p/Share
634 Added 1.94%
32,130 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
$9,993 $10.78 p/Share
927 Added 2.86%
31,496 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$9,995 $5.11 p/Share
1,956 Added 6.01%
30,569 Common Stock

Also insider at

TVTX
Travere Therapeutics, Inc. Healthcare
ACER
Acer Therapeutics Inc. Healthcare
SA

Steve Aselage

Director
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX